A cost-effectiveness analysis of in-vitro fertilization by maternal age and number of treatment attempts.
about
Disinvestment policy and the public funding of assisted reproductive technologies: outcomes of deliberative engagements with three key stakeholder groupsFemale ageing and reproductive outcome in assisted reproduction cyclesEvaluating Cost-effectiveness of Interventions That Affect Fertility and Childbearing: How Health Effects Are Measured Matters.Outcome of assisted reproductive technology in women aged 40 years and older.Comparison of lifestyle in fertile and infertile couples in Kermanshah during 2013The ASTUTE Health study protocol: deliberative stakeholder engagements to inform implementation approaches to healthcare disinvestmentEstimating the long-term effects of in vitro fertilization in Greece: an analysis based on a lifetime-investment modelEconomic evaluation of highly purified human menopausal gonadotropin versus recombinant human follicle-stimulating hormone in fresh and frozen in vitro fertilization/intracytoplasmic sperm-injection cycles in Sweden.Role of GnRH Neurons and Their Neuronal Afferents as Key Integrators between Food Intake Regulatory Signals and the Control of Reproduction.Assessing predictors for the success of GnRH antagonist protocol in reproductive women in IVF/ICSI - in fresh cycles.Should there be a female age limit on public funding for assisted reproductive technology?Effects of maternal ageing on ICSI outcomes and embryo development in relation to oocytes morphological characteristics of birefringent structures.Effect of maternal age on the outcomes of in vitro fertilization and embryo transfer (IVF-ET).Low-dose lisinopril in normotensive men with idiopathic oligospermia and infertility: a 5-year randomized, controlled, crossover pilot study.
P2860
Q33593080-D5F0562C-0D75-4B61-B9C4-E252A7418F3DQ34953523-223BB11F-CF0F-4C89-9CFB-60FAA19E6911Q35564876-3CDAA2BD-F966-4DC9-B4E8-687B22131272Q36076979-909137A7-5C1B-4727-9343-BBB717D6A044Q36260009-1988C39D-92E9-4225-94E3-BF38CFF7317AQ36462962-252614D9-B59F-4CF5-BA56-BF1A8B0908BBQ36961119-4F7E36ED-A5C4-423A-B333-51A2C1E075FBQ37099603-72153DB7-9F24-412B-B99E-6F4B80401790Q37206283-1810068E-AF16-4A09-969C-9D15390EEF74Q47135497-6C389EAC-8666-4233-8C95-24497BCEC401Q48323971-BCE9386E-8B44-4BAC-9179-8FB1569F3A5FQ48601609-7D66E505-6C07-425A-A4D6-3D36E81A6D3FQ48640835-2DB011B9-E8DE-4175-BEA0-D1039AD6B563Q50591364-11AF6D8E-3C0C-4B1C-BB97-02EFEFBFDA53
P2860
A cost-effectiveness analysis of in-vitro fertilization by maternal age and number of treatment attempts.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
A cost-effectiveness analysis ...... number of treatment attempts.
@en
A cost-effectiveness analysis ...... number of treatment attempts.
@nl
type
label
A cost-effectiveness analysis ...... number of treatment attempts.
@en
A cost-effectiveness analysis ...... number of treatment attempts.
@nl
prefLabel
A cost-effectiveness analysis ...... number of treatment attempts.
@en
A cost-effectiveness analysis ...... number of treatment attempts.
@nl
P2093
P2860
P356
P1433
P1476
A cost-effectiveness analysis ...... number of treatment attempts.
@en
P2093
Alison Griffiths
Chris Pardy
Ian S Fraser
Simon Eckermann
P2860
P304
P356
10.1093/HUMREP/DEP418
P407
P577
2010-01-26T00:00:00Z